| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Motilal Oswal Nifty MidSmall Healthcare Index Fund Reg (G) |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.40 |
| Equity |
100.04 |
| Trep |
0.36 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
39.22% |
| Top 10 Holdings |
60.73% |
| Top 25 Holdings |
93.13% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
77.19 |
| Healthcare |
22.85 |
| Cash |
-0.04 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.11 |
| PE Ratio |
41.09 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Lupin Limited |
9.88 |
| Fortis Health Care Ltd |
8.50 |
| Laurus Labs Limited |
7.57 |
| Aurobindo Pharma Limited |
6.87 |
| Glenmark Pharmaceuticals Limited |
6.40 |
| Alkem Laboratories Limited |
5.58 |
| Biocon Limited |
4.54 |
| Mankind Pharma Limited |
4.49 |
| IPCA Laboratories Limited |
3.76 |
| (5) Total outstanding exposure in derivative instruments as on April 30, 2026 is Rs. Nil. |
3.14 |
| J B Chemicals and Pharma Ltd |
2.95 |
| Krishna Inst of Medical Sciences Ltd. |
2.91 |
| Sai Life Sciences Limited |
2.60 |
| Gland Pharma Limited |
2.46 |
| Abbott India Limited |
2.32 |
| Neuland Laboratories Limited |
2.28 |
| Narayana Hrudalaya Ltd |
2.16 |
| Ajanta Pharma Limited |
2.10 |
| Wockhardt Limited |
2.04 |
| Dr Lal Path Labs Ltd |
1.88 |
| Granules India Limited |
1.79 |
| Piramal Pharma Limited |
1.77 |
| Natco Pharma Limited |
1.74 |
| Glaxosmithkline Pharma Ltd |
1.71 |
| One Source Specialty Pharma Ltd |
1.69 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
